PMID: 8460854May 1, 1993Paper

Prediction of cardiovascular death in men undergoing noninvasive evaluation for coronary artery disease

Annals of Internal Medicine
K MorrowJ Wallis

Abstract

To develop prediction rules from clinical and exercise test data identifying patients at high and low risk for cardiovascular events among a group of male veterans. Prognostic study with prospective gathering of data and routine follow-up of consecutive patients referred for exercise testing. Patients only underwent noninvasive evaluation for coronary artery disease. No validation cohort is yet available. A 1200-bed Veterans Affairs Medical Center. Of 3609 men referred for exercise testing between 1984 and 1990, 2546 patients remained evaluable after exclusion of those who underwent subsequent cardiac catheterization, those with significant valvular heart disease, and those who had previous coronary artery bypass surgery. Evaluation included recording of clinical data on a standardized form and a standard treadmill test followed by assessment of cardiovascular events. During a mean follow-up period (+/- SD) of 2.75 (+/- 18) years, 119 cardiovascular deaths and 44 nonfatal myocardial infarctions occurred in 2546 patients. The Cox proportional hazards model showed the following characteristics to be statistically independent predictors of time until cardiovascular death: history of congestive heart failure or digoxin use, exercis...Continue Reading

Citations

Mar 14, 2002·Clinical Cardiology·William F FearonVictor F Froelicher
May 28, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Stefano MuzzarelliMichael Johannes Zellweger
Dec 14, 2005·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Nili ZafrirAlexander Battler
Aug 7, 2007·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Matthew P SmelleyR Parker Ward
Apr 18, 2002·The American Journal of Medicine·Joshua M SpinJonathan Myers
May 19, 1998·Progress in Cardiovascular Diseases·B R Chaitman, D D Miller
May 11, 2001·Primary Care·C H EvansM H Ellestad
May 11, 2001·Primary Care·D B Mark
Oct 12, 2000·Journal of the American College of Cardiology·R A StewartI P Kay
Dec 12, 2001·Journal of the American College of Cardiology·K ShetlerJ Myers
Sep 21, 2000·The New England Journal of Medicine·X JouvenP Ducimetière
Mar 15, 2002·The New England Journal of Medicine·Jonathan MyersJ Edwin Atwood
Jun 4, 2002·Journal of Cardiopulmonary Rehabilitation·Peter F KokkinosBo Fernhall
Jun 23, 2009·Coronary Artery Disease·Andreas P MichaelidesChristodoulos I Stefanadis
Mar 31, 2007·BMC Cardiovascular Disorders·Mohan N BabapulleMark J Eisenberg
Jun 8, 2001·Sports Medicine·K ShetlerV Froelicher
Dec 10, 2013·Journal of Hypertension·Jari A LaukkanenRainer Rauramaa
Jan 12, 2001·The American Journal of Cardiology·J DornUNKNOWN National Exercise and Heart Disease Project Staff
Jun 16, 2014·European Journal of Internal Medicine·María Del Carmen Bouzas-MosqueraAlfonso Castro-Beiras
Sep 5, 2014·European Heart Journal Cardiovascular Imaging·Patrick T SiegristPhilipp A Kaufmann
Aug 4, 2012·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Traci L JurrensRobert B McCully
Apr 4, 2016·The Canadian Journal of Cardiology·Alda HuqiMario Marzilli
Mar 23, 2010·International Journal of Cardiology·Andreas P MichaelidesChristodoulos I Stefanadis
Sep 9, 2008·Progress in Cardiovascular Diseases·Vy-Van LeVictor Froelicher
May 21, 2008·The American Journal of Cardiology·Gregory D LewisThomas J Wang
Nov 27, 2007·The American Journal of Cardiology·Manish Prakash GuptaVictor Froelicher
Aug 31, 2007·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·P V Loar, R K Reynolds
Sep 4, 2007·Progress in Cardiovascular Diseases·Gaetano Antonio Lanza
Oct 20, 2007·Child: Care, Health and Development·F Russell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.